TNKS2
Basic information
Region (hg38): 10:91798426-91865475
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TNKS2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 41 | 41 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 3 | |||||
Total | 0 | 0 | 41 | 0 | 4 |
Variants in TNKS2
This is a list of pathogenic ClinVar variants found in the TNKS2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-91798715-G-A | not specified | Uncertain significance (Feb 06, 2023) | ||
10-91798715-G-C | not specified | Uncertain significance (Jun 16, 2024) | ||
10-91798751-G-A | not specified | Likely benign (May 10, 2024) | ||
10-91798761-C-T | not specified | Uncertain significance (Sep 29, 2023) | ||
10-91798764-C-T | not specified | Uncertain significance (Apr 21, 2022) | ||
10-91798767-G-C | Uncertain significance (Nov 08, 2023) | |||
10-91813016-T-A | not specified | Uncertain significance (Dec 17, 2023) | ||
10-91813054-G-A | not specified | Uncertain significance (Sep 09, 2021) | ||
10-91813060-A-G | not specified | Uncertain significance (Nov 27, 2023) | ||
10-91813137-T-A | not specified | Uncertain significance (Jul 27, 2021) | ||
10-91813162-C-T | not specified | Uncertain significance (Jun 29, 2023) | ||
10-91813227-C-T | Benign (Jan 06, 2022) | |||
10-91819285-A-G | not specified | Uncertain significance (Jun 03, 2022) | ||
10-91819544-G-T | not specified | Uncertain significance (Sep 20, 2023) | ||
10-91827038-A-G | not specified | Uncertain significance (Jun 21, 2022) | ||
10-91827200-G-A | not specified | Uncertain significance (Mar 03, 2023) | ||
10-91828378-A-G | not specified | Uncertain significance (Oct 25, 2022) | ||
10-91834033-T-G | Benign (Apr 04, 2018) | |||
10-91836961-T-G | not specified | Uncertain significance (Oct 03, 2022) | ||
10-91836963-G-A | not specified | Uncertain significance (Feb 12, 2024) | ||
10-91840597-A-C | not specified | Uncertain significance (Apr 25, 2023) | ||
10-91840654-G-A | not specified | Uncertain significance (Dec 16, 2023) | ||
10-91840657-G-A | not specified | Uncertain significance (May 04, 2022) | ||
10-91840660-G-C | not specified | Uncertain significance (Oct 05, 2023) | ||
10-91840723-G-A | Benign (Jan 21, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TNKS2 | protein_coding | protein_coding | ENST00000371627 | 27 | 66965 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000367 | 1.00 | 125709 | 0 | 39 | 125748 | 0.000155 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.12 | 368 | 580 | 0.635 | 0.0000281 | 7581 |
Missense in Polyphen | 170 | 313 | 0.54313 | 3988 | ||
Synonymous | -0.0363 | 214 | 213 | 1.00 | 0.0000108 | 2290 |
Loss of Function | 4.75 | 19 | 58.0 | 0.327 | 0.00000310 | 767 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000276 | 0.000273 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000278 | 0.000277 |
European (Non-Finnish) | 0.000188 | 0.000185 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000134 | 0.000131 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Poly-ADP-ribosyltransferase involved in various processes such as Wnt signaling pathway, telomere length and vesicle trafficking. Acts as an activator of the Wnt signaling pathway by mediating poly-ADP-ribosylation of AXIN1 and AXIN2, 2 key components of the beta-catenin destruction complex: poly-ADP- ribosylated target proteins are recognized by RNF146, which mediates their ubiquitination and subsequent degradation. Also mediates poly-ADP-ribosylation of BLZF1 and CASC3, followed by recruitment of RNF146 and subsequent ubiquitination. Mediates poly-ADP-ribosylation of TERF1, thereby contributing to the regulation of telomere length. May also regulate vesicle trafficking and modulate the subcellular distribution of SLC2A4/GLUT4-vesicles. Stimulates 26S proteasome activity. {ECO:0000269|PubMed:11739745, ECO:0000269|PubMed:11802774, ECO:0000269|PubMed:19759537, ECO:0000269|PubMed:21478859, ECO:0000269|PubMed:23622245}.;
- Pathway
- NAD+ biosynthetic pathways;Disease;Signaling by WNT;Signal Transduction;Regulation of PTEN stability and activity;Post-translational protein modification;Metabolism of proteins;Ub-specific processing proteases;PTEN Regulation;PIP3 activates AKT signaling;Deubiquitination;Signaling by WNT in cancer;Intracellular signaling by second messengers;Diseases of signal transduction;TCF dependent signaling in response to WNT;Degradation of AXIN;XAV939 inhibits tankyrase, stabilizing AXIN
(Consensus)
Recessive Scores
- pRec
- 0.125
Intolerance Scores
- loftool
- 0.519
- rvis_EVS
- -1.29
- rvis_percentile_EVS
- 5.08
Haploinsufficiency Scores
- pHI
- 0.633
- hipred
- Y
- hipred_score
- 0.648
- ghis
- 0.653
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.677
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tnks2
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;
Gene ontology
- Biological process
- protein polyubiquitination;protein ADP-ribosylation;Wnt signaling pathway;positive regulation of telomere maintenance via telomerase;multicellular organism growth;regulation of multicellular organism growth;protein localization to chromosome, telomeric region;protein auto-ADP-ribosylation;positive regulation of canonical Wnt signaling pathway;positive regulation of telomere capping;negative regulation of telomere maintenance via telomere lengthening
- Cellular component
- Golgi membrane;pericentriolar material;nuclear chromosome, telomeric region;nucleus;nuclear envelope;cytoplasm;cytosol;perinuclear region of cytoplasm
- Molecular function
- NAD+ ADP-ribosyltransferase activity;protein binding;enzyme binding;metal ion binding